Equity
AOCI
Edwards Lifesciences AOCI increased by 7.1% to -$221.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.0%, from -$254.50M to -$221.30M. Over 5 years (FY 2020 to FY 2025), AOCI shows a downward trend with a 8.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2014
Last reportedQ1 2026
How to read this metric
Large negative values often reflect unfavorable currency movements or a decline in the market value of the company's investment portfolio.
Detailed definition
A component of equity that aggregates unrealized gains and losses that are excluded from net income. This typically incl...
Peer comparison
Multinational corporations with significant overseas operations and large cash portfolios are more sensitive to this metric than domestic-only firms.
Metric ID:
aociHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$159.60M | -$155.40M | -$157.70M | -$186.60M | -$224.40M | -$256.00M | -$254.90M | -$255.40M | -$255.50M | -$250.10M | -$242.80M | -$233.30M | -$220.20M | -$252.50M | -$244.50M | -$254.50M | -$264.10M | -$250.40M | -$238.30M | -$221.30M |
| QoQ Change | — | +2.6% | -1.5% | -18.3% | -20.3% | -14.1% | +0.4% | -0.2% | -0.0% | +2.1% | +2.9% | +3.9% | +5.6% | -14.7% | +3.2% | -4.1% | -3.8% | +5.2% | +4.8% | +7.1% |
| YoY Change | — | — | — | — | -40.6% | -64.7% | -61.6% | -36.9% | -13.9% | +2.3% | +4.7% | +8.7% | +13.8% | -1.0% | -0.7% | -9.1% | -19.9% | +0.8% | +2.5% | +13.0% |
Range-$264.10M – -$155.40M
CAGR+7.1%
Avg YoY Growth-12.7%
Median YoY Growth-0.8%
Current Streak3 quarters growth
AOCI at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's aoci?
- Edwards Lifesciences (EW) reported aoci of -$221.30M in Q1 2026.
- How has Edwards Lifesciences's aoci changed year-over-year?
- Edwards Lifesciences's aoci increased by 13.0% year-over-year, from -$254.50M to -$221.30M.
- What is the long-term trend for Edwards Lifesciences's aoci?
- Over 5 years (2020 to 2025), Edwards Lifesciences's aoci has grown at a 8.1% compound annual growth rate (CAGR), from -$161.10M to -$238.30M.
- What does aoci mean?
- A bucket for 'paper' gains or losses on investments and currency changes that haven't been finalized yet.